Kymera Therapeutics (KYMR) Earnings Date & Reports

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

KYMR is expected to report earnings to rise 1.38% to -71 cents per share on July 31

Kymera Therapeutics KYMR Stock Earnings Reports

Q2'26

Est.

$-0.72

Q1'26

Beat

by $0.17

Q4'25

Missed

by $0.18

Q3'25

Missed

by $0.18

Q2'25

Missed

by $0.12

The last earnings report on April 30 showed earnings per share of -70 cents, beating the estimate of -87 cents. With 588.77K shares outstanding, the current market capitalization sits at 8.18B.

View a ticker or compare two or three

Compare

KYMR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for KYMR